SCHEMBL17806528

SCHEMBL17806528

NS(=O)(=O)NC(=O)c1ccc(I)c([N+](=O)[O-])c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 1/20 0.61
▸ MAPT P10636 3/20 0.46
▸ ALDH1A1 P00352 6/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ LMNA P02545 1/20 0.41
▸ HCAR3 P49019 1/20 0.41
▸ VCAM1 P19320 1/20 0.41
▸ CASP6 P55212 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ THRA P10827 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15208952 0.82 PARP1 (0.64) PARP1ALDH1A1SMN1; SMN2RAB9AMEN1
SCHEMBL27901177 0.79 PARP1 (0.69) PARP1MAPTALDH1A1SMN1; SMN2RAB9A
Iniparib SCHEMBL242006 0.77 PARP1 (1.00) PARP1MAPTALDH1A1SMN1; SMN2MEN1
Iniparib SCHEMBL29354973 0.77 PARP1 (1.00) PARP1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL10954211 0.76 PARP1 (0.74) PARP1MAPTALDH1A1SMN1; SMN2MEN1
SCHEMBL27515223 0.75 FLT1 (0.61) MAPTRAB9AMEN1KMT2ANPC1
SCHEMBL30995722 0.75 PARP1 (0.72) PARP1LMNAHCAR3CASP6
SCHEMBL8629267 0.75 PARP1 (0.72) PARP1MAPTALDH1A1SMN1; SMN2LMNA
SCHEMBL1766442 0.75 PARP1 (0.72) PARP1LMNAHCAR3CASP6
SCHEMBL14934251 0.74 PARP1 (0.57) PARP1MAPTALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089208-A2 SULFONAMIDE, SULFAMATE AND SULFAMIDE DERIVATIVES OF ANTI-CANCER AGENTS STICHTING MAASTRICHT RADIATION ONCOLOGY "MAASTRO-CLINIC" (NL) 2016-06-09 — — WO disclosed
Send feedback